John Sanders
Internal Medicine · Ashland, KYNPI 1790709749
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $565 and has fallen 80.7% since, to $109 in 2024.
Across 78 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$342
- Amgen$217
- Gilead$138
- Merck$137
- Johnson & Johnson$67
- Pfizer$65
- plus $603 from 20 others
What the payments were for
- Food & beverage$1,569100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $342 |
| Amgen | 12 | $217 |
| Gilead | 5 | $138 |
| Merck | 8 | $137 |
| Johnson & Johnson | 3 | $67 |
| Pfizer | 3 | $65 |
| Astellas Pharma US Inc | 4 | $64 |
| Seagen Inc. | 3 | $58 |
| Coherus Oncology, Inc. | 2 | $50 |
| Jazz Pharmaceuticals Inc. | 3 | $41 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| AstraZeneca | 2 | $40 |
| ADC Therapeutics America, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Tersera Therapeutics LLC | 1 | $31 |
| Boehringer Ingelheim | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Bristol Myers Squibb | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Electromed, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,569 in reported general payments places this provider in the 70th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Ashland
- Fares KhaterWhitesburg$412K
- Bernard BuchananOwensboro$185K
- David ManninoLexington$168K
- John PeppinCynthiana$108K
- Sanjay KaulBrownsville$69K
- John JonesHazard$63K
- Robert SasserLouisville$62K
- Justin LandeDanville$60K
- Sanjiv GuptaGrayson$49K
- Kelley McIntyreLouisville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.